Skip to main content

Table 4 Longitudinal change (12 months—baseline) of blood glucose metabolism and lipid profile

From: Effect of individual- versus collective-based nutritional-lifestyle intervention on the atherogenic index of plasma in children with obesity: a randomized trial

Variable

Individual intervention (n = 76)

Collective intervention

(n = 77)

p-value

Lipid

Total cholesterol (mmol/L)

− 0.20 (− 0.35 to − 0.05)

− 0.09 (− 0.004 to 0.18)

0.056

LDL cholesterol (mmol/L)

− 0.08 (− 0.17 to − 0.001)

− 0.17 (− 0.27 to − 0.07)

0.359

HDL cholesterol (mmol/L)

0.03 (− 0.02 to 0.08)

0.01 (− 0.03 to 0.05)

0.537

Triglycerides (mmol/L)

− 0.29 (− 0.38 to − 0.20)

− 0.15 (− 0.24 to − 0.03)

0.036

Apo A1 (g/L)

− 0.002 (− 0.05 to 0.05)

− 0.02 (− 0.10 to 0.06)

0.512

Apo B (g/L)

− 0.01 (− 0.08 to 0.06)

− 0.03 (− 0.08 to 0.02)

0.460

AIP

− 0.12 (− 0.16 to − 0.08)

− 0.05 (− 0.10 to 0.005)

0.013

Glucose metabolism

Glucose (mmol/L)

− 0.02 (− 0.11 to 0.07)

0.08 (− 0.002 to 0.16)

0.156

Insulin (pmol/L)

− 23.06 (− 38.39 to − 7.73)

− 20.35 (− 37.65 to − 3.06)

0.804

HOMA-IR

− 0.72 (− 1.21 to − 0.22)

− 0.21 (− 0.89 to 0.47)

0.095

HOMA-β%

− 58.60 (− 92.20 to − 25.00)

− 84.84 (− 142.74 to − 29.44)

0.390

QUICK index

0.01 (0.005 to 0.014)

0.001 (− 0.006 to 0.01)

0.447

TyG index

− 0.22 (− 0.30 to − 0.14)

− 0.08 (− 0.01 to 0.17)

0.005

  1. Values are mean (95% CI)
  2. LDL low-density-lipoprotein, HDL high-density-lipoprotein, Apo A1 apolipoprotein A1, Apo B apolipoprotein B, AIP atherogenic index of plasma, HOMA-IR homeostatic model assessment of insulin resistance, HOMA-β% homeostatic model assessment of β-cell function, QUICK quantitative insulin sensitivity check, TyG triglyceride-glucose